People in the News
David Onions has been promoted to chief medical officer of Invitrogen, a new position. He used to be chief scientific officer for BioReliance, a company Invitrogen acquired in 2004.
As CMO, Onions will be responsible for guiding Invitrogen's scientific efforts as it moves into areas more closely associated with medical research and closer to patients.
He is a personal chair in veterinary molecular virology at the University of Glasgow. Onions holds a PhD from the University of Cambridge and a BVSc from Bristol University.
Genospectra has appointed George Bers to the newly created position of executive vice president of commercial operations.
Bers will be responsible for overseeing the company's sales, marketing, and business development activities, Genospectra said.
Bers has held various senior executive management positions at NuGen, Beckman Coulter, Nanogen, and Bio-Rad Laboratories, Genospectra said. He holds a BA from Duke University and an MS in biochemistry from Georgetown University.
Products & Services
Applied Biosystems has commercially released TaqMan microRNA assays for the detection and quantitation of mature human miRNA expression levels.
The assays require small starting samples, between 1-10 nanograms of RNA or equivalent, which allows researchers to conserve samples, ABI said. The assays are pre-designed and validated probe and primer sets with a flexible format, and accommodate both large initial screening panels and in-depth further screening to determine differential expression levels of specific miRNAs, the company said.